D L Carlson Investment Group Inc Repligen Corp Transaction History

D L Carlson Investment Group Inc

  • $507 Million
  • Q1 2025

A detailed history of D L Carlson Investment Group Inc transactions in Repligen Corp stock. As of the latest transaction made, D L Carlson Investment Group Inc holds 5,361 shares of RGEN stock, worth $630,131. This represents 0.13% of its overall portfolio holdings.

Number of Shares
5,361
Previous 5,787 7.36%
Holding current value
$630,131
Previous $832,000 18.03%
% of portfolio
0.13%
Previous 0.15%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$127.24 - $174.24 $54,204 - $74,226
-426 Reduced 7.36%
5,361 $682,000
Q4 2024

Feb 12, 2025
SELL
$123.41 - $160.92 $37,393 - $48,758
-303 Reduced 4.98%
5,787 $832,000
Q3 2024

Nov 13, 2024
SELL
$119.79 - $167.35 $5,749 - $8,032
-48 Reduced 0.78%
6,090 $906,000
Q2 2024

Aug 14, 2024
SELL
$120.0 - $182.95 $49,200 - $75,009
-410 Reduced 6.26%
6,138 $773,000
Q1 2024

May 14, 2024
SELL
$170.78 - $208.42 $18,785 - $22,926
-110 Reduced 1.65%
6,548 $1.2 Million
Q4 2023

Feb 16, 2024
SELL
$114.17 - $185.35 $199,112 - $323,250
-1,744 Reduced 20.76%
6,658 $1.2 Million
Q3 2023

Nov 02, 2023
SELL
$138.78 - $176.51 $27,478 - $34,948
-198 Reduced 2.3%
8,402 $1.34 Million
Q2 2023

Aug 09, 2023
SELL
$138.42 - $180.31 $48,308 - $62,928
-349 Reduced 3.9%
8,600 $1.22 Million
Q1 2023

May 17, 2023
SELL
$154.26 - $198.1 $60,624 - $77,853
-393 Reduced 4.21%
8,949 $1.51 Million
Q4 2022

Feb 13, 2023
SELL
$162.42 - $220.56 $69,028 - $93,738
-425 Reduced 4.35%
9,342 $1.58 Million
Q3 2022

Nov 18, 2022
SELL
$160.42 - $256.21 $411,156 - $656,666
-2,563 Reduced 20.79%
9,767 $1.83 Million
Q2 2022

Aug 10, 2022
SELL
$140.68 - $188.02 $45,721 - $61,106
-325 Reduced 2.57%
12,330 $2 Million
Q1 2022

May 12, 2022
SELL
$161.19 - $257.96 $226,955 - $363,207
-1,408 Reduced 10.01%
12,655 $2.38 Million
Q4 2021

Feb 14, 2022
SELL
$247.59 - $304.47 $355,786 - $437,523
-1,437 Reduced 9.27%
14,063 $3.72 Million
Q3 2021

Nov 05, 2021
SELL
$194.77 - $324.21 $190,290 - $316,753
-977 Reduced 5.93%
15,500 $4.48 Million
Q2 2021

Aug 12, 2021
SELL
$165.87 - $220.95 $91,394 - $121,743
-551 Reduced 3.24%
16,477 $3.29 Million
Q1 2021

May 11, 2021
SELL
$180.37 - $226.26 $747,994 - $938,300
-4,147 Reduced 19.58%
17,028 $3.31 Million
Q4 2020

Feb 09, 2021
SELL
$148.08 - $206.57 $282,832 - $394,548
-1,910 Reduced 8.27%
21,175 $4.06 Million
Q3 2020

Nov 13, 2020
SELL
$122.51 - $158.27 $83,306 - $107,623
-680 Reduced 2.86%
23,085 $3.41 Million
Q2 2020

Aug 13, 2020
SELL
$94.33 - $140.48 $132,533 - $197,374
-1,405 Reduced 5.58%
23,765 $2.94 Million
Q1 2020

May 07, 2020
SELL
$84.96 - $109.14 $126,675 - $162,727
-1,491 Reduced 5.59%
25,170 $2.43 Million
Q4 2019

Feb 10, 2020
SELL
$73.84 - $93.08 $51,392 - $64,783
-696 Reduced 2.54%
26,661 $2.47 Million
Q3 2019

Nov 05, 2019
SELL
$76.65 - $95.51 $44,073 - $54,918
-575 Reduced 2.06%
27,357 $2.1 Million
Q2 2019

Aug 19, 2019
SELL
$54.2 - $85.95 $82,871 - $131,417
-1,529 Reduced 5.19%
27,932 $2.4 Million
Q1 2019

May 02, 2019
SELL
$49.45 - $62.8 $144,047 - $182,936
-2,913 Reduced 9.0%
29,461 $1.74 Million
Q4 2018

Feb 12, 2019
SELL
$48.26 - $68.88 $89,522 - $127,772
-1,855 Reduced 5.42%
32,374 $1.71 Million
Q3 2018

Nov 13, 2018
SELL
$46.8 - $58.97 $31,589 - $39,804
-675 Reduced 1.93%
34,229 $1.9 Million
Q2 2018

Aug 10, 2018
SELL
$35.26 - $47.04 $46,895 - $62,563
-1,330 Reduced 3.67%
34,904 $1.64 Million
Q1 2018

May 11, 2018
SELL
$30.92 - $37.27 $27,828 - $33,543
-900 Reduced 2.42%
36,234 $1.31 Million
Q4 2017

Feb 09, 2018
SELL
$32.53 - $38.92 $73,843 - $88,348
-2,270 Reduced 5.76%
37,134 $1.35 Million
Q3 2017

Nov 13, 2017
BUY
$36.98 - $46.06 $1.46 Million - $1.81 Million
39,404
39,404 $1.51 Million

Others Institutions Holding RGEN

# of Institutions
495
Shares Held
57.6M
Call Options Held
75.6K
Put Options Held
521K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.52B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track D L Carlson Investment Group Inc Portfolio

Follow D L Carlson Investment Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D L Carlson Investment Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on D L Carlson Investment Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email